Generate Biomedicines GENB
Generate Biomedicines, Inc. · Nasdaq · Pharmaceutical Preparations
$15.38+16.43%close on Oct. 28, 2026 · volume 3.9M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Sept. 1, 2026 | Frances Arnold director | Sold 10b5-1 plan | 1,000 | $16.00 | $16,002 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 4 →Regulation FD disclosure · Financial statements and exhibits
Results of operations and financial condition · Financial statements and exhibits